Caring Brands (CABR) CEO redeems 1.5M shares in issuer deal

Rhea-AI Filing Summary

Caring Brands, Inc. Chief Executive Officer Dr. Glynn Wilson reported a disposition of 1,500,000 shares of common stock back to the company. The shares were redeemed at approximately $0.50 per share under a Share Redemption Agreement signed on March 19, 2026.

After this issuer redemption, Dr. Wilson beneficially owns 500,000 shares of common stock and 172,592 restricted stock units, none of which have vested. He therefore continues to hold a meaningful equity stake that aligns his interests with other shareholders.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WILSON GLYNN

(Last) (First) (Middle)

C/O CARING BRANDS, INC.,

130 S INDIAN, SUITE 100

(Street)

FORT PIERCE FLORIDA 34950

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Caring Brands, Inc. [ CABR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/27/2026		D(1)		1,500,000	D	$0.5	672,592(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents redemption of 1,500,000 shares of common stock of the Issuer at approximately $0.50 per share pursuant to that certain Share Redemption Agreement signed by the Reporting Person and the Issuer on March 19, 2026.

2. The number of shares of common stock beneficially owned following the reported transaction includes Dr. Wilson's ownership of (i) 126,720 restricted stock units of common stock of the Issuer of which zero have vested, (ii) 45,872 restricted stock units of common stock of the Issuer of which zero have vested, and (iii) 500,000 shares of common stock.

	/s/ Dr. Glynn Wilson	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Caring Brands (CABR) report for its CEO?

Caring Brands reported that CEO Dr. Glynn Wilson disposed of 1,500,000 common shares through a redemption by the company at about $0.50 per share. The transaction was executed under a Share Redemption Agreement signed on March 19, 2026.

Was the Caring Brands (CABR) CEO’s Form 4 transaction a market sale?

No, the Form 4 shows an issuer disposition, not an open-market sale. Dr. Wilson’s 1,500,000 shares were redeemed by the company at roughly $0.50 per share under a negotiated Share Redemption Agreement, rather than sold on a stock exchange.

How many Caring Brands (CABR) shares did the CEO give up in this transaction?

Dr. Glynn Wilson disposed of 1,500,000 shares of Caring Brands common stock. The filing notes these were redeemed by the issuer at approximately $0.50 per share, reflecting a structured agreement between the CEO and the company rather than ordinary trading activity.

How many Caring Brands (CABR) shares does the CEO own after the redemption?

Following the redemption, Dr. Wilson beneficially owns 500,000 common shares plus 172,592 restricted stock units. The filing specifies that none of these restricted stock units have vested yet, so his current stake combines both fully owned and unvested equity-based awards.

What agreement governed the Caring Brands (CABR) CEO share redemption?

The disposition was executed under a Share Redemption Agreement between Dr. Wilson and Caring Brands. According to the Form 4, this agreement was signed on March 19, 2026 and provided for redemption of 1,500,000 common shares at about $0.50 per share.

Does the Caring Brands (CABR) CEO still hold unvested equity awards?

Yes. The Form 4 notes Dr. Wilson’s beneficial ownership includes 126,720 restricted stock units and 45,872 additional restricted stock units. None of these RSUs have vested yet, so they represent potential future common share ownership if vesting conditions are met.